All episodes
October '18 Updates
Flu Vaccine Use with Immunotherapy
Talazoparib
P1: Tamoxifen for Breast Cancer Risk Reduction
Dacomitinib, cemiplimab & #oncopharm updates
Duvelisib
The Pseudomonas Exotoxin Drug
*Bonus Pod* World Marrow Donor Day '18
5-Fluorouracil
Ask OncoPharm (Part 1) & RELEVANCE
Influenza Vaccination during Chemo
Small Cell Lung Cancer: Established & Recent Advances
Mogamulizumab & August updates
Rituximab
Iobenguane I-131 & Lusutrombopag
Ivosidenib
A Brief History of Pemetrexed
Paclitaxel
Happy Fourth!
Encorafenib & Binimetinib
The Immunotherapy Two Step
Ondansetron Origins
Less is More & More
ASCO18 & Under the Radar Abstracts
Avatrombopag
PERSEPHONE: Bonus Pod
Cytarabine
Dual TKI Use & Frontline Dara
Methotrexate
AACR Update
NSABP-14
Vincristine
HOPA Highlights and Catching Up with NEJOncology
HOPA Preview
Landmark Testicular Cancer Study PVB (& BEP & EP)
Cycling thru the CDK Inhibitors
It's All Immunotherapy Nowadays
Apalutamide
Landmarks in Oncology Pharmacy: CMF
Foundations in Oncology Pharmacy: Doxorubicin
Updates in Oncology Pharmacy: Lu-177
Landmarks in Oncology Pharmacy: MOPP
Foundations in Oncology Pharmacy: Cisplatin
Updates in Oncology Pharmacy: Adjuvant pertuzumab & nilotinib discontinuation (CML)
Landmarks in Oncology Pharmacy: Acute Leukemia in 1958
2017 Was A Good Year
Tales of Brave Iressa
Adjuvant TKIs?
Acalabrutinib